Table of Contents Introduction Atrial Fibrillation - Overview Atrial Fibrillation - Therapeutics Development Atrial Fibrillation - Therapeutics Assessment Atrial Fibrillation - Companies Involved in Therapeutics Development Atrial Fibrillation - Drug Profiles Atrial Fibrillation - Dormant Projects Atrial Fibrillation - Discontinued Products Atrial Fibrillation - Product Development Milestones Appendix

List of Tables Number of Products under Development for Atrial Fibrillation, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products under Development by Universities/Institutes, H1 2019 Products under Development by Companies, H1 2019 Products under Development by Companies, H1 2019 (Contd..1), H1 2019 Products under Development by Universities/Institutes, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Atrial Fibrillation - Pipeline by Acesion Pharma Aps, H1 2019 Atrial Fibrillation - Pipeline by Allergan Plc, H1 2019 Atrial Fibrillation - Pipeline by AnaBios Corp, H1 2019 Atrial Fibrillation - Pipeline by ARCA biopharma Inc, H1 2019 Atrial Fibrillation - Pipeline by Boston Pharmaceuticals Inc, H1 2019 Atrial Fibrillation - Pipeline by Correvio Pharma Corp, H1 2019 Atrial Fibrillation - Pipeline by Dong-A Socio Holdings Co Ltd, H1 2019 Atrial Fibrillation - Pipeline by Gilead Sciences Inc, H1 2019 Atrial Fibrillation - Pipeline by HUYA Bioscience International LLC, H1 2019 Atrial Fibrillation - Pipeline by InCarda Therapeutics Inc, H1 2019 Atrial Fibrillation - Pipeline by Merck & Co Inc, H1 2019 Atrial Fibrillation - Pipeline by Nissan Chemical Corp, H1 2019 Atrial Fibrillation - Pipeline by OMEICOS Therapeutics GmbH, H1 2019 Atrial Fibrillation - Pipeline by The Geneva Biotech Center SA, H1 2019 Atrial Fibrillation - Pipeline by Toa Eiyo Ltd, H1 2019 Atrial Fibrillation - Pipeline by Verseon Corp, H1 2019 Atrial Fibrillation - Dormant Projects, H1 2019 Atrial Fibrillation - Dormant Projects, H1 2019 (Contd..1), H1 2019 Atrial Fibrillation - Dormant Projects, H1 2019 (Contd..2), H1 2019 Atrial Fibrillation - Discontinued Products, H1 2019 Atrial Fibrillation - Discontinued Products, H1 2019 (Contd..1), H1 2019List of Figures Number of Products under Development for Atrial Fibrillation, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products by Top 10 Targets, H1 2019 Number of Products by Stage and Top 10 Targets, H1 2019 Number of Products by Top 10 Mechanism of Actions, H1 2019 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019 Number of Products by Routes of Administration, H1 2019 Number of Products by Stage and Routes of Administration, H1 2019 Number of Products by Molecule Types, H1 2019 Number of Products by Stage and Molecule Types, H1 2019

Acesion Pharma Aps Allergan Plc AnaBios Corp ARCA biopharma Inc Boston Pharmaceuticals Inc Correvio Pharma Corp Dong-A Socio Holdings Co Ltd Gilead Sciences Inc HUYA Bioscience International LLC InCarda Therapeutics Inc Merck & Co Inc Nissan Chemical Corp OMEICOS Therapeutics GmbH The Geneva Biotech Center SA Toa Eiyo Ltd Verseon Corp